BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 16856127)

  • 1. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
    Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
    J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic clustering in MPZ mutations.
    Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
    Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.
    Sabet A; Li J; Ghandour K; Pu Q; Wu X; Kamholz J; Shy ME; Cambi F
    Neurology; 2006 Oct; 67(7):1141-6. PubMed ID: 17030746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
    Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
    Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes.
    Bai Y; Ianokova E; Pu Q; Ghandour K; Levinson R; Martin JJ; Ceuterick-de Groote C; Mazanec R; Seeman P; Shy ME; Li J
    Arch Neurol; 2006 Dec; 63(12):1787-94. PubMed ID: 17172621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
    Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
    Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral neuropathies caused by mutations in the myelin protein zero.
    Shy ME
    J Neurol Sci; 2006 Mar; 242(1-2):55-66. PubMed ID: 16414078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset Charcot-Marie-Tooth type 1B disease caused by a novel Leu190fs mutation in the myelin protein zero gene.
    Kochański A; Kabzińska D; Drac H; Ryniewicz B; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
    Eur J Paediatr Neurol; 2004; 8(4):221-4. PubMed ID: 15261887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
    Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
    J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two families of Charcot-Marie-Tooth disease with Adie's pupil, axonal neuropahy and the Thr124Met mutation in the peripheral myelin protein zero gene].
    Misu K; Yoshihara T; Yamamoto M; Hattori N; Nagamatu M; Mukai E; Takegami T; Sobue G
    Rinsho Shinkeigaku; 2000 Feb; 40(2):149-54. PubMed ID: 10835936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
    Eggers SD; Keswani SC; Melli G; Cornblath DR
    Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B.
    Matsuyama W; Nakagawa M; Takashima H; Osame M
    Acta Neuropathol; 2002 May; 103(5):501-8. PubMed ID: 11935267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common themes in peripheral neuropathy disease genes.
    Snipes GJ; Orfali W
    Cell Biol Int; 1998 Nov; 22(11-12):815-35. PubMed ID: 10873294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy.
    Briani C; Adami F; Cavallaro T; Taioli F; Ferrari S; Fabrizi G
    Muscle Nerve; 2008 Jul; 38(1):921-3. PubMed ID: 18563718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia.
    Luigetti M; Modoni A; Renna R; Silvestri G; Ricci E; Montano N; Tasca G; Papacci M; Monforte M; Conte A; Pomponi MG; Sabatelli M
    Clin Neurol Neurosurg; 2010 Nov; 112(9):794-7. PubMed ID: 20537790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
    Nowakowski A; Kochański A
    Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked phenotypic variation in a family with a new myelin protein zero mutation.
    Szabo A; Züchner S; Siska E; Mechler F; Molnar MJ
    Neuromuscul Disord; 2005 Nov; 15(11):760-3. PubMed ID: 16198109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.